BrainStorm Gets FDA Approval For New Experimental Drug To Treat Progressive MS
The Israeli-American biotechnology company is also currently conducting a Phase III clinical trial for the treatment of amyotrophic lateral sclerosis (ALS).
December 18, 2018
Swiss Biotech Multinational Opens Innovation Center In Haifa
Lonza Pharma & Biotech launched a new collaborative center for research into new technologies for medicine manufacturing.
November 20, 2018
German Firm Merck Sets Up $25M Fund To Tap Into Israeli Biotech Startups
The company and its partners plan to invest in up to four early-stage Israeli startups a year over five years
February 20, 2018